aldesleukin FDA Link

a recombinant human IL-2, marketed for the treatment of metastatic renal cell carcinoma; BAY 50-4798 is a variant

Also Known As:

Proleukin; BAY 50-4798; 2-133-Interleukin 2 (human reduced), 125-L-serine-

Pharmalogical Action Categories:

aldesleukin Products